Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics [Yahoo! Finance]
Adlai Nortye Ltd. - American Depositary Shares (ANL)
Company Research
Source: Yahoo! Finance
Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it will deliver an oral presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held from October 22-26, 2025, in Boston, MA. Presentation details are as follows: Abstract title: Discovery of AN4035: A novel CEACAM5-targeting antibody drug conjugate (ADC) armed with a proprietary pan-RAS(ON) inhibitor payload, designed to broaden the therapeutic window Date and Time: Saturday, October 25, 2025; 11:45 AM – 12:15 PM ET Session Title: Spotlight on Proffered Papers 3: Novel Therapeutic Agents Location: Level 3, Ballroom AB, Hynes Convention Center, Boston, MA The Company will issue a further press release detailing the scientific rationale and data highlights for AN4035 once the abstract is made public on the AACR portal on October 22, 2025 About Adlai Nor
Show less
Read more
Impact Snapshot
Event Time:
ANL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANL alerts
High impacting Adlai Nortye Ltd. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ANL
News
- Adlai Nortye to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Adlai Nortye to Participate in Upcoming Investor ConferencesGlobeNewswire
- Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsGlobeNewswire
- Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsGlobeNewswire
- Adlai Nortye (NASDAQ:ANL) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
ANL
Sec Filings
- 12/3/25 - Form 6-K
- 10/22/25 - Form 6-K
- 9/16/25 - Form S-8
- ANL's page on the SEC website